SCHEMBL4093746

SCHEMBL4093746

CCOC(=O)c1sc(N2CCN(c3ccccc3OC)CC2)nc1-c1ccccc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 3/20 0.57
ALDH1A1 P00352 6/20 0.54
HSD17B10 Q99714 2/20 0.54
HPGD P15428 2/20 0.52
PKM P14618 1/20 0.52
DHODH Q02127 2/20 0.51
MAPT P10636 3/20 0.51
HTT P42858 3/20 0.51
MEN1 O00255 2/20 0.51
KMT2A Q03164 2/20 0.51
CASP1 P29466 1/20 0.51
SMN1; SMN2 Q16637 1/20 0.51
GAA P10253 2/20 0.50
ALOX15 P16050 1/20 0.50
CDC7 O00311 1/20 0.50
DBF4 Q9UBU7 1/20 0.50
CYP1A2 P05177 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
KDM4E B2RXH2 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL347027 0.87 ALDH1A1 (0.53) LMNAALDH1A1HPGDMAPTHTT
SCHEMBL4086525 0.85 DHODH (0.59) LMNAALDH1A1HSD17B10HPGDDHODH
SCHEMBL347670 0.81 GAA (0.55) ALDH1A1HPGDPKMMAPTHTT
SCHEMBL4630926 0.80 DHODH (0.54) LMNAALDH1A1HSD17B10HPGDDHODH
SCHEMBL19909753 0.77 ALDH1A1 (0.62) LMNAALDH1A1HSD17B10HPGDDHODH
SCHEMBL16597702 0.75 ALDH1A1 (0.50) ALDH1A1HSD17B10HPGDDHODHHTT
SCHEMBL16075307 0.75 CKS1B (0.49) ALDH1A1HSD17B10HPGDDHODHHTT
SCHEMBL3892246 0.74 ALDH1A1 (0.51) ALDH1A1HSD17B10HPGDDHODHMEN1
SCHEMBL1561049 0.73 ALDH1A1 (0.71) ALDH1A1HSD17B10HPGDDHODHMEN1
SCHEMBL14345630 0.73 DHODH (0.72) DHODHMEN1KMT2AGAACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists ARGENTA DISCOVERY LIMITED (GB) 2009-09-03 US disclosed
EP-1922312-A1 THIAZOLE COMPOUNDS AND THEIR USE AS PGD2 ANTAGONISTS Argenta Discovery Limited (GB) 2008-05-21 EP disclosed
WO-2007028999-A1 THIAZOLE COMPOUNDS AND THEIR USE AS PGD2 ANTAGONISTS ARGENTA DISCOVERY LIMITED (GB) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090221604-A1 Thiazole Compounds and Their Use as PGD2 Antagonists PTGDR2, PTGDR, PTGER2 LMNA 2889/4885ALDH1A1 3327/4885HSD17B10 746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.